KEBOMED A/S: Financial statements 2025
CVR: 28490704
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
KEBOMED A/S (CVR 28490704) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 47,572,239 and a net result of DKK 9,827,524 compared with DKK 9,233,510 the year before. That is an increase of 11.5% compared with the year before. Equity in the 2025 report amounted to DKK 68,941,956. The solvency ratio was 51.3%. The company had 22 employees in the financial year.
- Gross Profit
- DKK 47,572,239
- Profit/Loss
- DKK 9,827,524
- Equity
- DKK 68,941,956
- Total Assets
- DKK 134,439,250
- Employees
- 22
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 47.6M | 9.8M | 68.9M | 22 |
| 2024 | - | 42.6M | 9.2M | 59.1M | 22 |
| 2023 | - | 41.3M | 9.5M | 49.9M | 22 |
| 2022 | - | 39.3M | 9.1M | 40.3M | 23 |
| 2021 | - | 41.5M | 12.9M | 31.2M | 25 |
Official annual report
How creditworthy is KEBOMED A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
KEBOMED A/S has won the tender "Genudbud Utensilier til Gastroenterologi" issued by Region Sjælland worth 19,639,408 DKK.
KEBOMED A/S has won the tender "EU-udbud vedrørende utensilier til Gastroenterologi" issued by Region Sjælland worth 53,786,978 DKK.
About KEBOMED A/S
KEBOMED A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2005. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named KEBO MED A/S. The management consists of Henrik Schjødt. The board consists of Niels Søren Frederik Kornerup (chair), Henrik Schjødt and Søren Dalmark Kornerup. The company is owned by Kebomed Europe Holding AG. The company has 23 employees (2026). In 2026, the company reported a gross profit of DKK 52,977,983 and a net result of DKK 13,110,236 compared with DKK 9,827,524 the year before. Equity in the 2026 report amounted to DKK 36,352,192.
